SCR-LIP-000287 · Claim · machine-readable JSON →

In a case-control study, carriers of the IL-6 rs1800795 G allele had a 5.92-fold higher risk of lipedema (OR=5.92, 95%CI 1.983–17.711, p<0.001), and DXA-derived body composition indices (reduced WHR 0.73 vs 0.79, higher lower-limb FM% 48.90% vs 42.55%) combined with genetic analysis were proposed as tools for differential diagnosis between lipedema, normal-weight obesity, and obesity.

Created: 2026-05-31 · Last updated: 2026-05-31

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

Evidence (1)

• DOI:10.26355/eurrev_202003_20690 — supporting · cross sectional · 2020
  The article proposes composite body-composition indices and IL-6 genotyping as promising tools for diagnosis and differential analysis of lipedema, indirectly supporting that screening/diagnostic tools can help identify it; however it does

Context (PECO)

Answers these questions

• Is lipedema underdiagnosed, and can screening tools help identify it? supporting

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log

• 2026-05-31 — created · auto-ingested for SQ-LIP-000004

← All claims